Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33667349
2.
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.
Nature
; 600(7889): 530-535, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670266
3.
High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies.
Proc Natl Acad Sci U S A
; 121(3): e2314730121, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198525
4.
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
Proc Natl Acad Sci U S A
; 119(20): e2120976119, 2022 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549549
5.
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Proc Natl Acad Sci U S A
; 118(36)2021 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417349
6.
Role of a fluid-phase PRR in fighting an intracellular pathogen: PTX3 in Shigella infection.
PLoS Pathog
; 14(12): e1007469, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30532257
7.
The Orchestra and Its Maestro: Shigella's Fine-Tuning of the Inflammasome Platforms.
Curr Top Microbiol Immunol
; 397: 91-115, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27460806
8.
The Deep-Sea Polyextremophile Halobacteroides lacunaris TB21 Rough-Type LPS: Structure and Inhibitory Activity towards Toxic LPS.
Mar Drugs
; 15(7)2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28653982
9.
Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation.
Proc Natl Acad Sci U S A
; 110(46): E4345-54, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24167293
10.
Thermophiles as potential source of novel endotoxin antagonists: the full structure and bioactivity of the lipo-oligosaccharide from Thermomonas hydrothermalis.
Chembiochem
; 15(14): 2146-55, 2014 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25171597
11.
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody.
bioRxiv
; 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293237
12.
Chemistry and biology of the potent endotoxin from a Burkholderia dolosa clinical isolate from a cystic fibrosis patient.
Chembiochem
; 14(9): 1105-15, 2013 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23733445
13.
Prior SARS-CoV-2 Infection Enhances Initial mRNA Vaccine Response with a Lower Impact on Long-Term Immunity.
Immunohorizons
; 7(10): 635-651, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819998
14.
mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5.
Nat Commun
; 14(1): 1734, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36977711
15.
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response.
Nat Commun
; 14(1): 53, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599850
16.
2D NMR Analysis as a Sensitive Tool for Evaluating the Higher-Order Structural Integrity of Monoclonal Antibody against COVID-19.
Pharmaceutics
; 14(10)2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36297417
17.
Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana.
Front Plant Sci
; 13: 956741, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131799
18.
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations.
Commun Biol
; 5(1): 903, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36056181
19.
Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection.
Nat Commun
; 13(1): 2263, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477725
20.
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees.
Nat Commun
; 13(1): 3375, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697673